VanEck Pharmaceutical ETF (NASDAQ:PPH) Shares Sold by Sanctuary Advisors LLC

Sanctuary Advisors LLC reduced its holdings in VanEck Pharmaceutical ETF (NASDAQ:PPH) by 94.7% in the 3rd quarter, according to its most recent disclosure with the Securities and Exchange Commission. The fund owned 2,358 shares of the company’s stock after selling 41,736 shares during the quarter. Sanctuary Advisors LLC’s holdings in VanEck Pharmaceutical ETF were worth $209,000 as of its most recent filing with the Securities and Exchange Commission.

A number of other hedge funds have also recently added to or reduced their stakes in the business. International Assets Investment Management LLC acquired a new position in shares of VanEck Pharmaceutical ETF in the 2nd quarter valued at about $86,000. Total Clarity Wealth Management Inc. lifted its holdings in shares of VanEck Pharmaceutical ETF by 59.5% during the 2nd quarter. Total Clarity Wealth Management Inc. now owns 10,718 shares of the company’s stock valued at $980,000 after acquiring an additional 3,998 shares in the last quarter. Renaissance Technologies LLC lifted its holdings in shares of VanEck Pharmaceutical ETF by 85.0% during the 2nd quarter. Renaissance Technologies LLC now owns 25,900 shares of the company’s stock valued at $2,369,000 after acquiring an additional 11,902 shares in the last quarter. Blair William & Co. IL increased its holdings in VanEck Pharmaceutical ETF by 15.4% in the 2nd quarter. Blair William & Co. IL now owns 6,941 shares of the company’s stock valued at $635,000 after purchasing an additional 924 shares in the last quarter. Finally, Thrivent Financial for Lutherans purchased a new position in VanEck Pharmaceutical ETF in the second quarter valued at about $16,088,000.

VanEck Pharmaceutical ETF Stock Down 0.8 %

NASDAQ PPH opened at $87.17 on Monday. The stock has a market cap of $644.19 million, a PE ratio of 21.04 and a beta of 0.72. The business has a 50 day moving average price of $89.54 and a two-hundred day moving average price of $92.72. VanEck Pharmaceutical ETF has a fifty-two week low of $81.03 and a fifty-two week high of $99.51.

VanEck Pharmaceutical ETF Increases Dividend

The firm also recently disclosed a dividend, which will be paid on Monday, December 30th. Shareholders of record on Friday, December 27th will be paid a dividend of $0.411 per share. The ex-dividend date is Friday, December 27th. This is a positive change from VanEck Pharmaceutical ETF’s previous dividend of $0.36.

VanEck Pharmaceutical ETF Company Profile

The VanEck Pharmaceutical ETF (PPH) is an exchange-traded fund that is based on the MVIS US Listed Pharmaceutical 25 index, a market-cap-weighted index of 25 of the largest global pharmaceutical firms. PPH was launched on Feb 1, 2000 and is managed by VanEck.